Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lartigue, M. F. Articles by Nicolas-Chanoine, M.-H. Search for Related Content PubMed PubMed Citation Articles by Lartigue, M. F. Articles by Nicolas-Chanoine, M.-H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2002, p. 4035-4037, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4035-4037.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Promoters P3, Pa/Pb, P4, and P5 Upstream from bla_TEM Genes and Their Relationship to ß-Lactam Resistance

Marie Frédérique Lartigue,^1,2 Véronique Leflon-Guibout,^1,2 Laurent Poirel,^3,4 Patrice Nordmann,^3,4 and Marie-Hélène Nicolas-Chanoine^1,2*

Service de Microbiologie-Hygiène, Hôpital Ambroise Paré Assistance Publique-Hôpitaux de Paris, Boulogne,¹ Faculté Paris Ile-de-France Ouest, Université Versailles Saint-Quentin-en-Yvelines, Saint-Quentin-en-Yvelines,² Service de Bactériologie-Virologie, Hôpital Bicêtre,³ Assistance Publique-Hôpitaux de Paris,⁴ Le Kremlin Bicêtre, and Faculté de Médecine Université Paris XI, Paris, France⁵

Received 23 May 2002/ Returned for modification 24 July 2002/ Accepted 25 August 2002

Top Abstract Text References

 
Using an isogenic system, we have determined the impact that the four promoters known to control bla_TEM gene expression have on ß-lactamase activity. For both TEM-1 and TEM-30, this activity gradually increased in relation to the presence of promoters P3, Pa/Pb, and P4 upstream of the corresponding gene. Promoter P5, only found upstream of the bla_TEM-1B gene, was related to the highest expression of this gene.

Top Abstract Text References

 
The extensive nucleotide sequence analysis of plasmid-mediated bla_TEM genes performed over the last 15 years because of their role in resistance to extended-spectrum cephalosporins and to amoxicillin-clavulanate has allowed us to observe that the expression of these genes is controlled by four different promoters (3, 6). The first promoter, called P3 (Fig. 1,) corresponds to the promoter of the bla_TEM-1A gene which is located on a Tn3 transposon and plasmid pBR322 (10). The second promoter, called Pa/Pb and found upstream of the bla_TEM-2 gene, is composed, in fact, by two overlapping promoters resulting from the mutation CT at position 32 according to the Sutcliffe numbering system (10). The -35 and -10 regions of promoter Pa are TTGAAG and TACGCT, respectively, whereas the -35 and -10 regions of promoter Pb are GTGATA and TAATGT, respectively, the first 2 nucleotides of the -10 region of Pa corresponding to the last 2 nucleotides of the -35 region of Pb (Fig. 1). Chen et al. (2), studying the separately cloned promoters P3 and Pa/Pb, showed that the Pb sequence which was present in the fragment containing the promoter P3 did not work as a promoter and that the overlapping promoter P3 were stronger than promoter P3, with the increase in strength resulting from both the strength of Pa and the cooperative activity of Pa and Pb. The third promoter, called P4 by Goussard et al. (3), differs from promoter P3 by the substitution G162T (Sutcliffe numbering system) corresponding to the first nucleotide of the -10 region of the promoter (TACAAT instead of GACAAT). This substitution makes the sequence of the -10 region of promoter P4 closer to the consensus sequence (TATAAT) (Fig. 1). We suggest that the fourth promoter, which we have recently published, be called P5 (7). This promoter has the same sequence as promoter P3 at the -10 region but has a sequence at the -35 region (TTGAAA) closer to the consensus sequence (TTGACA) than that of promoter P3 (TTCAAA) (Fig. 1). To assess and compare the respective impact of the four promoters on ß-lactam resistance, we established an isogenic system in which the only difference consisted of the type of promoter upstream from bla_TEM genes coding for either a ß-lactamase susceptible (TEM-1) or resistant (TEM-30 or IRT-2) to class A ß-lactamase inhibitors.

View larger version (24K): [in this window] [in a new window]

FIG. 1. Nucleotide sequences of promoters P3, Pa/Pb, P4, and P5 of blaTEM genes. The sequences of the -35 and -10 regions of promoters P3, P4, and P5 are boxed by solid lines, whereas these of the overlapping promoters Pa/Pb are boxed by broken lines. Boldface letters indicate the mutations which led to the creation of promoters Pa/Pb, P4, and P5. The numbers under sequences indicate Sutcliffe numbering positions.

By using primers 5'-ATA AAA TTC TTG AAG AC-3' and 5'-TTA CCA ATG CTT AAT CA-3', four bla_TEM-1B genes, each preceded by one of the four promoters, were amplified and cloned from previously published Escherichia coli isolates (6). The bla_TEM-30 gene coding for the inhibitor-resistant TEM-30 or IRT-2 enzyme was also amplified and cloned from previously published E. coli isolates but only with promoter P3, Pa/Pb, or P4 upstream from it, as a bla_TEM-30 gene controlled by promoter P5 has not been discovered thus far (6). Plasmid pPCR Script (Cam^r) (Stratagene, La Jolla, Calif.) and E. coli strain Epicurian Coli XL10-Gold (Stratagene) were used in the first stage of the cloning experiments. After the sequences of inserted fragments (promoter and coding region) were checked (automated cycle sequencing system on a Perkin-Elmer R377 sequencer), the fragments were then cloned into the BamHI-restricted and dephosphorylated plasmid pACYC184 (Tet^r and Cam^r) and expressed in E. coli strain NM554 (8). The size of the inserts and their insertion in the opposite orientation of the promoter of the pACYC184 tetracycline resistance-encoding gene were assessed by restriction analyses with BamHI and AseI enzymes.

The E. coli NM554 transformants containing the different recombinant plasmids were then tested in three independent experiments for ß-lactam susceptibility by using the agar dilution method on Mueller-Hinton agar with a Steers multiple inoculator and 10⁴ CFU per spot. The ß-lactamase activity of each transformant was also tested from the crude extracts of three independent cultures, as previously described (5). Briefly, ß-lactamase was extracted from 100 ml of an exponential-growth-phase culture at 37°C in Trypticase soy broth containing amoxicillin (100 µg/ml) combined with chloramphenicol (30 µg/ml). Bacterial suspensions were disrupted by sonication, and the ß-lactamase activity was measured from the crude extracts with a Pharmacia UV2000 spectrophotometer, using benzylpenicillin (100 µM) as the substrate. One unit of ß-lactamase activity was defined as the amount of enzyme which hydrolyzed 1 µM benzylpenicillin per min, and the specific activity was defined as the ß-lactamase activity per milligram of protein.

As indicated in Table 1, ß-lactamase activity as well as MICs of amoxicillin-clavulanate, ticarcillin-clavulanate, piperacillin, and cephalothin gradually increased from the E. coli transformant expressing the bla_TEM-1B gene controlled by the P3 promoter to that expressing the bla_TEM-1B gene controlled by the P5 promoter, with higher values for the two types of parameters when bla_TEM-1B was controlled by the P4 promoter than when it was controlled by the Pa/Pb promoters. Concerning ticarcillin, the concentrations used in this study did not allow us to observe a gradual increase in MICs in relation to the promoter type. For piperacillin-tazobactam, we observed different levels of MICs: low MICs, from 1 to 2 µg/ml for the transformants whose bla_TEM-1B gene was controlled by promoters P3 and Pa/Pb, respectively, and high MICs, from 128 to 512 µg/ml for those whose bla_TEM-1B gene was under the control of promoters P4 and P5, respectively. The first two transformants were categorized as susceptible to piperacillin-tazobactam, whereas the last two were categorized as resistant following the recommendations of the French Antibiogram Committee (9). These results indicate that the CG substitution, which occurred in the -35 region of promoter P5, is more efficient in terms of promoter strength than the GT substitution, which occurred in the -10 region of promoter P4. In fact, promoter P5 possesses the trimer TTG in the -35 region that was considered by Kobayashi et al. (4) to be the most essential sequence for determining promoter strength. However, although the overlapping promoters Pa/Pb possess the trimer TTG in the -35 region of promoter Pa, they were related to a weaker ß-lactamase activity than that related to promoter P5. This difference suggests that other nucleotide motifs than TTG in the promoter region might be involved in gene expression.

View this table: [in this window] [in a new window]

TABLE 1. ß-Lactam susceptibility and ß-lactamase activity of TEM-1- and TEM-30 (IRT-2)-producing E. coli transformants according to the type of promoter upstream from the blaTEM-1B and blaTEM-30B genes

Concerning the three transformants containing the bla_TEM-30gene, they differed from each other with regard to the ß-lactamase activity and the ß-lactam MICs with the exception of cephalothin. The lowest MICs, regardless of the penicillins tested, were found in the transformant harboring the bla_TEM-30B gene preceded by promoter P3, whereas the highest MICs were found in the transformant harboring the bla_TEM-30B gene controlled by promoter P4; intermediate MICs were found in the transformant harboring the bla_TEM-30 gene preceded by promoters Pa/Pb (Table 1). For cephalothin, all of the transformants were susceptible. For piperacillin-tazobactam, only those transformants with promoters P3 and Pa/Pb upstream from the bla_TEM-30B gene were susceptible. For piperacillin, only the transformant with promoter P3 was susceptible. For the transformants with bla_TEM-30B, the lowest ß-lactamase activity was observed in the transformant harboring the bla_TEM-30B gene with promoter P3, whereas the highest activity was observed in the transformant harboring the bla_TEM-30B gene with promoter P4.

Overall, the increase in ß-lactamase activity observed in relation to the presence of promoters P3, Pa/Pb, and P4 was demonstrated by using either the bla_TEM-1B gene coding for TEM-1 or the bla_TEM-30B gene coding for TEM-30 or IRT-2. Thus, we were able to compare not only the expression of a given bla_TEM gene in relation to different promoters but also the expression of different bla_TEM genes in relation to a given promoter. In this study, it has been unambiguously demonstrated that, for any one promoter, the ß-lactamase activity measured by using benzylpenicillin as the substrate was higher for TEM-30 or IRT-2 than for TEM-1 from which the IRT enzyme is derived (1). However, despite this higher ß-lactamase activity, the MICs of the penicillins tested were lower, with the exception of amoxicillin-clavulanate, for the transformants producing TEM-30 or IRT-2 than for those producing TEM-1 (Table 1). This result emphasizes that MICs are linked to both the type of promoters upstream of the TEM-encoding gene and to the biochemical properties of the TEM enzyme.

In conclusion, although our isogenic system has probably slightly overestimated MICs and ß-lactamase activity for all of the transformants, as the vector used (pACYC184) is a low-number but not a single-copy plasmid, it has allowed us to compare the roles that the four promoters that have been described thus far and that are upstream from the bla_TEM genes have on ß-lactam resistance according to the type of TEM enzyme involved.

 
* Corresponding author. Mailing address: Hôpital Ambroise Paré, Service de Microbiologie-Hygiène, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. Phone: 33-1-49-09-55-40. Fax: 33-1-49-09-59-21. E-mail: marie-helene.nicolas-chanoine{at}apr.ap-hop-paris.fr.

Top Abstract Text References

 

1
1. Chaibi, E. B., D. Sirot, G. Paul, and R. Labia. 1999. Inhibitor-resistant TEM ß-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.[Abstract/Free Full Text]
2
2. Chen, C. 1984. Two improved promoter sequences for the ß-lactamase expression arising from a single base pair substitution. Nucleic Acids Res. 12:3219-3234.[Abstract/Free Full Text]
3
3. Goussard, S., and P. Courvalin. 1999. Updated sequence information for TEM beta-lactamase genes. Antimicrob. Agents Chemother. 43:367-370.[Abstract/Free Full Text]
4
4. Kobayashi, M., K. Nagata, and A. Ishihama. 1990. Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength. Nucleic Acids Res. 18:7367-7372.[Abstract/Free Full Text]
5
5. Laurent, F., L. Poirel, T. Naas, E. B. Chaibi, R. Labia, P. Boiron, and P. Nordmann. 1999. Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica. Antimicrob. Agents Chemother. 43:1644-1650.[Abstract/Free Full Text]
6
6. Leflon-Guibout, V., B. Heym, and M. H. Nicolas-Chanoine. 2000. Updated sequence information and proposed nomenclature for bla_TEM genes and their promoters. Antimicrob. Agents Chemother. 44:3232-3234.[Abstract/Free Full Text]
7
7. Leflon-Guibout, V., V. Speldooren, B. Heym, and M.-H. Nicolas-Chanoine. 2000. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla_TEM genes. Antimicrob. Agents Chemother. 44:2709-2714.[Abstract/Free Full Text]
8
8. Raleigh, E. A., N. E. Murray, H. Revel, R. M. Blumenthal, D. Westaway, A. D. Reith, P. W. Rigby, J. Elhai, and D. Hanahan. 1988. McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloning. Nucleic Acids Res. 16:1563-1575.[Abstract/Free Full Text]
9
9. Soussy, C. J., G. Carret, J. D. Cavallo, H. Chardon, C. Chidiac, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, V. Jarlier, R. Leclercq, M. H. Nicolas-Chanoine, A. Philippon, C. Quentin, B. Rouveix, and J. Sirot. 2000. Antibiogram Committee of the French Microbiology Society. Report 2000-2001. Pathol. Biol. 48:832-871.[Medline]
10
10. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.[Abstract/Free Full Text]

---

Antimicrobial Agents and Chemotherapy, December 2002, p. 4035-4037, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4035-4037.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Mulvey, M. R., Boyd, D. A. (2009). TEM-168, a Heretofore Laboratory-Derived TEM {beta}-Lactamase Variant Found in an Escherichia coli Clinical Isolate. Antimicrob. Agents Chemother. 53: 4955-4956 [Full Text]  
• Karami, N., Martner, A., Enne, V. I., Swerkersson, S., Adlerberth, I., Wold, A. E. (2007). Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 60: 1142-1145 [Abstract] [Full Text]  
• Tristram, S., Jacobs, M. R., Appelbaum, P. C. (2007). Antimicrobial Resistance in Haemophilus influenzae. Clin. Microbiol. Rev. 20: 368-389 [Abstract] [Full Text]  
• Robin, F., Delmas, J., Schweitzer, C., Tournilhac, O., Lesens, O., Chanal, C., Bonnet, R. (2007). Evolution of TEM-Type Enzymes: Biochemical and Genetic Characterization of Two New Complex Mutant TEM Enzymes, TEM-151 and TEM-152, from a Single Patient. Antimicrob. Agents Chemother. 51: 1304-1309 [Abstract] [Full Text]  
• Robin, F., Delmas, J., Archambaud, M., Schweitzer, C., Chanal, C., Bonnet, R. (2006). CMT-Type {beta}-Lactamase TEM-125, an Emerging Problem for Extended-Spectrum {beta}-Lactamase Detection.. Antimicrob. Agents Chemother. 50: 2403-2408 [Abstract] [Full Text]  
• Robin, F., Delmas, J., Chanal, C., Sirot, D., Sirot, J., Bonnet, R. (2005). TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 {beta}-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5). Antimicrob. Agents Chemother. 49: 4443-4447 [Abstract] [Full Text]  
• Delmas, J., Robin, F., Bittar, F., Chanal, C., Bonnet, R. (2005). Unexpected Enzyme TEM-126: Role of Mutation Asp179Glu. Antimicrob. Agents Chemother. 49: 4280-4287 [Abstract] [Full Text]  
• Tristram, S. G., Hawes, R., Souprounov, J. (2005). Variation in selected regions of blaTEM genes and promoters in Haemophilus influenzae. J Antimicrob Chemother 56: 481-484 [Abstract] [Full Text]  
• Baraniak, A., Fiett, J., Mrowka, A., Walory, J., Hryniewicz, W., Gniadkowski, M. (2005). Evolution of TEM-Type Extended-Spectrum {beta}-Lactamases in Clinical Enterobacteriaceae Strains in Poland. Antimicrob. Agents Chemother. 49: 1872-1880 [Abstract] [Full Text]  
• Walckenaer, E., Poirel, L., Leflon-Guibout, V., Nordmann, P., Nicolas-Chanoine, M.-H. (2004). Genetic and Biochemical Characterization of the Chromosomal Class A {beta}-Lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica. Antimicrob. Agents Chemother. 48: 305-312 [Abstract] [Full Text]  
• Nelson, E. C., Segal, H., Elisha, B. G. (2003). Outer membrane protein alterations and blaTEM-1 variants: their role in {beta}-lactam resistance in Klebsiella pneumoniae. J Antimicrob Chemother 52: 899-903 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lartigue, M. F. Articles by Nicolas-Chanoine, M.-H. Search for Related Content PubMed PubMed Citation Articles by Lartigue, M. F. Articles by Nicolas-Chanoine, M.-H.